Literature DB >> 15317018

Cubic liquid-crystalline nanoparticles.

Da Yang1, Bruce Armitage, Seth R Marder.   

Abstract

Cubic liquid-crystalline nanoparticles prepared from aqueous dispersions of cubic lipid-water phases are kinetically stable in the presence of certain dispersing agents. The properties of cubic nanoparticles from monoolein-water and other lipid-water systems have been examined with a variety of experimental techniques. The cubic nanoparticles can be stabilized by polymerization of the reactive lipids in cubic lipid assemblies. Several low-energy-input methods have been developed to facilitate the production and application of cubic nanoparticles. The ability to incorporate and deliver lipophilic, amphiphilic, and water-soluble molecules in a controlled manner and the good biocompatibility of cubic nanoparticles make them excellent candidates for drug-delivery applications.

Entities:  

Year:  2004        PMID: 15317018     DOI: 10.1002/anie.200301683

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  11 in total

Review 1.  In vitro and ex vivo corneal penetration and absorption models.

Authors:  Priyanka Agarwal; Ilva D Rupenthal
Journal:  Drug Deliv Transl Res       Date:  2016-12       Impact factor: 4.617

Review 2.  Cubic phases of ternary amphiphile-water systems.

Authors:  Scott Fraser; Frances Separovic; Anastasios Polyzos
Journal:  Eur Biophys J       Date:  2009-06-16       Impact factor: 1.733

3.  Bicontinuous cubic liquid crystalline nanoparticles for oral delivery of Doxorubicin: implications on bioavailability, therapeutic efficacy, and cardiotoxicity.

Authors:  Nitin K Swarnakar; Kaushik Thanki; Sanyog Jain
Journal:  Pharm Res       Date:  2013-11-12       Impact factor: 4.200

4.  Glyceryl monooleate/poloxamer 407 cubic nanoparticles as oral drug delivery systems: I. In vitro evaluation and enhanced oral bioavailability of the poorly water-soluble drug simvastatin.

Authors:  Jie Lai; Jianming Chen; Yi Lu; Jing Sun; Fuqiang Hu; Zongning Yin; Wei Wu
Journal:  AAPS PharmSciTech       Date:  2009-07-28       Impact factor: 3.246

5.  Stealth, biocompatible monoolein-based lyotropic liquid crystalline nanoparticles for enhanced aloe-emodin delivery to breast cancer cells: in vitro and in vivo studies.

Authors:  May S Freag; Yosra Sr Elnaggar; Doaa A Abdelmonsif; Ossama Y Abdallah
Journal:  Int J Nanomedicine       Date:  2016-09-20

6.  Cubosomes from hierarchical self-assembly of poly(ionic liquid) block copolymers.

Authors:  Hongkun He; Khosrow Rahimi; Mingjiang Zhong; Ahmed Mourran; David R Luebke; Hunaid B Nulwala; Martin Möller; Krzysztof Matyjaszewski
Journal:  Nat Commun       Date:  2017-01-16       Impact factor: 14.919

7.  Pharmacokinetics and enhanced oral bioavailability in beagle dogs of cyclosporine A encapsulated in glyceryl monooleate/poloxamer 407 cubic nanoparticles.

Authors:  Jie Lai; Yi Lu; Zongning Yin; Fuqiang Hu; Wei Wu
Journal:  Int J Nanomedicine       Date:  2010-02-02

8.  Cubic phase nanoparticles for sustained release of ibuprofen: formulation, characterization, and enhanced bioavailability study.

Authors:  Linghui Dian; Zhiwen Yang; Feng Li; Zhouhua Wang; Xin Pan; Xinsheng Peng; Xintian Huang; Zhefei Guo; Guilan Quan; Xuan Shi; Bao Chen; Ge Li; Chuanbin Wu
Journal:  Int J Nanomedicine       Date:  2013-02-26

9.  Lipid-based liquid crystalline nanoparticles as oral drug delivery vehicles for poorly water-soluble drugs: cellular interaction and in vivo absorption.

Authors:  Ni Zeng; Xiaoling Gao; Quanyin Hu; Qingxiang Song; Huimin Xia; Zhongyang Liu; Guangzhi Gu; Mengyin Jiang; Zhiqing Pang; Hongzhuan Chen; Jun Chen; Liang Fang
Journal:  Int J Nanomedicine       Date:  2012-07-13

10.  Novel piperine-loaded Tween-integrated monoolein cubosomes as brain-targeted oral nanomedicine in Alzheimer's disease: pharmaceutical, biological, and toxicological studies.

Authors:  Yosra S R Elnaggar; Samar M Etman; Doaa A Abdelmonsif; Ossama Y Abdallah
Journal:  Int J Nanomedicine       Date:  2015-08-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.